跳至主要内容
临床试验/CTRI/2022/06/043540
CTRI/2022/06/043540尚未招募不适用

Influence of microbiome and mechanism during cervical cancer progression

Science for Equity Empowerment and Development1 个研究点 分布在 1 个国家目标入组 260 人开始时间: 2022年1月7日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
260
试验地点
1
主要终点
The present study aims at the identification, characterization, and elucidation of relevant pathways and targets responsible for tumor progression cervical cancer upon HPV infection in relation to the co-inhabiting microbiome.

研究概览

简要总结

The main objective of the study is to identify bacterial biomarkers, elucidate pathways that are responsible for tumor progression, and target the identified biological markers (pathways/proteins) by treating with specific sets of chemotherapeutic agents.

研究设计

研究类型
Observational

入排标准

年龄范围
21.00 Year(s) 至 65.00 Year(s)(—)
性别
Female

入选标准

  • Women within the age group of 21-65 years with or without pre-malignant
  • malignant cervical lesions will be included in the study.

排除标准

  • Women who are pregnant and /or lactating at the time of the study, women who have undergone hysterectomy adenocarcinoma of the cervix
  • Women who have been diagnosed and have already started treatment for cervical lesions and malignancies will be excluded.

结局指标

主要结局

The present study aims at the identification, characterization, and elucidation of relevant pathways and targets responsible for tumor progression cervical cancer upon HPV infection in relation to the co-inhabiting microbiome.

时间窗: 4 weeks

次要结局

  • Not applicable(Not applicable)

研究者

发起方
Science for Equity Empowerment and Development
申办方类型
Government funding agency

研究点 (1)

Loading locations...

相似试验